开放性眼外伤患者行Ⅱ期玻璃体切除手术的时机选择
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

西京医院临床应用研究课题(No.JSYXM02); 空军军医大学临床研究项目(No.2022LC2247); 西京医院医务人员技术提升项目(No.2023XJSM20)


Timing of stage Ⅱ vitrectomy in patients with open ocular trauma
Author:
Affiliation:

Fund Project:

Clinical Application Research Project of Xijing Hospital(No.JSYXM02); Clinical Research Project of Air Force Medical University(No.2022LC2247); Clinical Technology Enhancement Project of Xijing Hospital(No.2023XJSM20)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的: 观察开放性眼外伤不同时间点行玻璃体切除手术的临床疗效,以探讨Ⅱ期玻璃体手术的时机选择。

    方法:回顾性系列病例研究。纳入2022-06/2023-02就诊于我院眼科的开放性眼外伤患者60例60眼,按Ⅰ期规范化急诊救治手术时间与Ⅱ期玻璃体视网膜手术的不同间隔时间分为治疗组A(间隔时间≤14 d,32例32眼)和治疗组B(间隔时间>14 d,28例28眼)。治疗组A中眼球破裂伤16眼(50%),穿通伤13眼(41%),贯通伤3眼(9%); 治疗组B中眼球破裂伤15眼(54%),穿通伤12眼(43%),贯通伤1眼(4%)。术后随访6 mo,对比观察两组患者的治疗效果。

    结果:玻璃体切除手术前两组患者间视力无差异(P>0.05)。术后6 mo,治疗组A中10眼(31%)视力显著提高,21眼(66%)视力有效提高,1眼(3%)视力无改善; 治疗组B中,5眼(18%)视力显著提高,16眼(57%)视力有效提高,7眼(25%)视力无变化,两组比较有差异(U=322.5,P=0.032)。治疗组A中继发性青光眼、硅油依赖、玻璃体再积血、眼球萎缩与治疗组B比较无显著差异(均P>0.05); 治疗组A术后随访未见外伤性增生性玻璃体视网膜病变(TPVR),显著低于治疗组B(P<0.05)。

    结论:开放性眼外伤Ⅱ期玻璃体视网膜手术在Ⅰ期救治手术后2 wk内完成预后相对较好。

    Abstract:

    AIM:To observe the clinical efficacy of vitrectomy at different times for open ocular trauma and explore the timing of stage Ⅱ vitrectomy.

    METHODS: Retrospective case series study. A total of 60 cases(60 eyes)with open ocular trauma who visited our ophthalmology department from June 2022 to February 2023 were included. They were divided into treatment group A(interval ≤14 d)and treatment group B(interval >14 d)based on the interval between the stage Ⅰ emergency treatment surgery and the stage Ⅱ vitreoretinal surgery. Among the 32 cases(32 eyes)in the treatment group A, 16 eyes(50%)had eyeball rupture, 13 eyes(41%)had penetrating injury, and 3 eyes(9%)had perforating injury. Among the 28 cases(28 eyes)in the treatment group B, 15 eyes(54%)had eyeball rupture, 12 eyes(43%)had penetrating injury, and one eye(4%)had perforating injury. The two groups of patients were followed-up for 6 mo after surgery, and the treatment effects were compared.

    RESULTS:There was no statistically significant difference in visual acuity between the two groups of patients before vitrectomy(P>0.05). In the treatment group A, 10 eyes(31%)had significantly improved visual acuity, 21 eyes(66%)had effectively enhanced visual acuity, and 1 eye(3%)had no improvement in visual acuity at 6 mo after surgery. Among the 28 eyes in the treatment group B, 5 eyes(18%)had significantly improved vision, 16 eyes(57%)had effectively enhanced vision, and 7 eyes(25%)had no change in vision, with statistically significant difference between the two groups(U=322.5, P=0.032). There was no significant difference between the treatment group A and the treatment group B in complications such as secondary glaucoma, silicone oil dependence, vitreous hemorrhage, and eyeball atrophy(P>0.05). There was no evidence of traumatic proliferative vitreoretinopathy(TPVR)in the treatment group A during postoperative follow-up, which was significantly lower than that of the treatment group B(P<0.05).

    CONCLUSION:The prognosis of the stage Ⅱ vitrectomy for open ocular injury is relatively good after completing the stage Ⅰ surgery within 2 wk.

    参考文献
    相似文献
    引证文献
引用本文

马春霞,杨霞霞,田超伟,等.开放性眼外伤患者行Ⅱ期玻璃体切除手术的时机选择.国际眼科杂志, 2024,24(4):630-633.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-10-17
  • 最后修改日期:2024-02-29
  • 录用日期:
  • 在线发布日期: 2024-03-21
  • 出版日期:
文章二维码